C1ORF26 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.265200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.127000E-01
Normal-vs-Stage2
2.320200E-01
Normal-vs-Stage3
3.844900E-03
Normal-vs-Stage4
6.806600E-01
Stage1-vs-Stage2
7.426800E-01
Stage1-vs-Stage3
1.208630E-01
Stage1-vs-Stage4
3.218400E-01
Stage2-vs-Stage3
7.537900E-02
Stage2-vs-Stage4
2.962600E-01
Stage3-vs-Stage4
1.163210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.103800E-01
Normal-vs-AfricanAmerican
8.693400E-01
Normal-vs-Asian
2.332400E-01
Caucasian-vs-AfricanAmerican
5.825900E-02
Caucasian-vs-Asian
8.450600E-01
AfricanAmerican-vs-Asian
7.737900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.108600E-01
Normal-vs-Female
2.449600E-01
Male-vs-Female
8.313800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.234800E-01
Normal-vs-Age(41-60Yrs)
3.286000E-01
Normal-vs-Age(61-80Yrs)
1.956400E-01
Normal-vs-Age(81-100Yrs)
1.193400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.592400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.707200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.941200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.657600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.019000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.144600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.787900E-02
Normal-vs-Daily Drinker
1.113840E-01
Normal-vs-Weekly Drinker
2.718000E-01
Normal-vs-Occasional Drinker
1.673990E-01
Normal-vs-Social Drinker
3.606600E-01
Non Drinker-vs-Daily Drinker
5.806800E-01
Non Drinker-vs-Weekly Drinker
7.052800E-01
Non Drinker-vs-Occasional Drinker
6.648600E-01
Non Drinker-vs-Social Drinker
5.238600E-01
Daily Drinker-vs-Weekly Drinker
4.778400E-01
Daily Drinker-vs-Occasional Drinker
4.093600E-01
Daily Drinker-vs-Social Drinker
3.580800E-01
Weekly Drinker-vs-Occasional Drinker
9.921200E-01
Weekly Drinker-vs-Social Drinker
8.473400E-01
Occasional Drinker-vs-Social Drinker
8.122400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.289520E-02
Normal-vs-Grade 2
8.696300E-03
Normal-vs-Grade 3
8.319700E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.027800E-01
Grade 1-vs-Grade 3
3.359800E-02
Grade 1-vs-Grade 4
1.289520E-02
Grade 2-vs-Grade 3
1.816800E-01
Grade 2-vs-Grade 4
8.696300E-03
Grade 3-vs-Grade 4
8.319700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.900370E-01
Normal-vs-NonDiabetic
9.414000E-02
Diabetic-vs-NonDiabetic
7.728400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.620200E-02
Normal-vs-NoPancreatitis
1.379220E-01
Pancreatitis-vs-NoPancreatitis
6.062800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.005400E-01
Normal-vs-N1
2.094600E-01
N0-vs-N1
8.597200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.664600E-01
Normal-vs-TP53-NonMutant
6.504000E-01
TP53-Mutant-vs-TP53-NonMutant
6.991800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
